Table 1 Patient’s characteristics
From: Functional and clinical significance of ROR1 in lung adenocarcinoma
Patient’s Characteristics | no. (%) |
|---|---|
Sex | |
 Male | 26/56 (46.4%) |
 Female | 30/56 (53.6%) |
Race | |
 Caucasian | 56/56 (100%) |
Stage of disease at diagnosis | |
 I/II/IIIA | 52/56 (92.9%) |
 IIIB/IV | 4/56 (7.1%) |
Histologic Type | |
 Adenocarcinoma | 56/56 (100%) |
Mutation present | |
 ROR1 | 16/56 (28.6%) |
 EGFR | 5/56 (8.9%) |
 KRAS | 26/56 (46.4%) |
 ALK | 1/9 (11.1%) |
 BRAF | 1/54 (1.9%) |
 HER2 | 1/55 (1.8%) |
 TTF-1 | 45/56 (80.3%) |
 ROS1 | 0/45 (0%) |